ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Assets
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Other Operating Assets of $13.29 thousand for the 12-month period ending 2014-09-30, per its 10-K filed 2014-11-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2014-11-25
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2014-09-30 was $1.89K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2014-06-30 was -$125.00K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2013-09-30 was -$2.00, a 100.64% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2013-06-30 was -$212.50K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2014 was $13.29K, a 633.68% increase from fiscal 2013.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2013 was $1.81K, a 94.08% decline from fiscal 2012.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2012 was $30.60K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2011 was -$18.47K, a 116.09% decline from fiscal 2010.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed | Increase (Decrease) in Other Operating Assets 98 month | Increase (Decrease) in Other Operating Assets 101 month | Increase (Decrease) in Other Operating Assets 104 month | Increase (Decrease) in Other Operating Assets 107 month | Increase (Decrease) in Other Operating Assets 110 month | Increase (Decrease) in Other Operating Assets 113 month | Increase (Decrease) in Other Operating Assets 116 month | Increase (Decrease) in Other Operating Assets 119 month | Increase (Decrease) in Other Operating Assets 122 month | Increase (Decrease) in Other Operating Assets 125 month | Increase (Decrease) in Other Operating Assets 128 month | Increase (Decrease) in Other Operating Assets 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $1.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | -$123.12K derived: sum of 2 quarters · filed 2014-11-25 | $13.29K 10-K · filed 2014-11-25 | ||||||||||||||
| 2014-06-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $11.40K 10-Q · filed 2014-08-12 | |||||||||||||||
| 2014-03-31 | $136.40K 10-Q · filed 2014-05-06 | $301.97K 10-Q · filed 2014-05-06 | |||||||||||||||
| 2013-12-31 | $165.57K 10-Q · filed 2014-02-04 | ||||||||||||||||
| 2013-09-30 | -$2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | -$212.51K derived: sum of 2 quarters · filed 2014-11-25 | -$10.63K derived: sum of 3 quarters · filed 2014-11-25 | $1.81K 10-K · filed 2014-11-25 | $165.57K 10-K · filed 2013-12-18 | ||||||||||||
| 2013-06-30 | -$212.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | -$10.63K derived: sum of 2 quarters · filed 2014-08-12 | $1.81K 10-Q · filed 2014-08-12 | $2.13K derived: sum of 4 quarters · filed 2014-11-25 | $165.57K 10-Q · filed 2013-08-07 | ||||||||||||
| 2013-03-31 | $201.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | $214.32K 10-Q · filed 2014-05-06 | $214.63K derived: sum of 3 quarters · filed 2014-11-25 | $378.07K 10-Q · filed 2013-05-09 | |||||||||||||
| 2012-12-31 | $12.44K 10-Q · filed 2014-02-04 | $12.76K derived: sum of 2 quarters · filed 2014-11-25 | $115.65K 10-Q · filed 2013-02-13 | ||||||||||||||
| 2012-09-30 | $314.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $30.60K 10-K · filed 2014-11-25 | $6.85K 10-K · filed 2012-12-28 | $103.21K 10-K · filed 2012-12-28 | |||||||||||||
| 2012-06-30 | $30.29K 10-Q · filed 2013-08-07 | $126.65K 10-Q · filed 2012-08-13 | |||||||||||||||
| 2012-03-31 | $96.36K 10-Q · filed 2012-05-08 | ||||||||||||||||
| 2011-12-31 | $1.00 10-Q · filed 2013-02-13 | $0.00 derived: sum of 2 quarters · filed 2013-02-13 | $96.36K 10-Q · filed 2012-02-09 | ||||||||||||||
| 2011-09-30 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | -$18.47K 10-K · filed 2012-12-28 | $96.36K 10-Q · filed 2012-08-13 | ||||||||||||||
| 2011-06-30 | -$18.47K 10-Q · filed 2012-08-13 | $96.36K 10-Q · filed 2011-08-08 | |||||||||||||||
| 2010-12-31 | -$96.36K 10-Q · filed 2012-02-09 | -$50.48K derived: sum of 2 quarters · filed 2012-02-09 | |||||||||||||||
| 2010-09-30 | $45.88K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $114.83K 10-K · filed 2011-12-20 | |||||||||||||||
| 2010-06-30 | $68.95K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |